Contribution of sensorimotor function to risk and pathogenic mechanisms of Alzheimer's disease and related dementias
感觉运动功能对阿尔茨海默病和相关痴呆的风险和致病机制的贡献
基本信息
- 批准号:10318172
- 负责人:
- 金额:$ 72.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAccelerometerAddressAdultAgeAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAlzheimer’s disease biomarkerAmyloid beta-ProteinAtherosclerosis Risk in CommunitiesAtrophicAuditoryBaltimoreBiological MarkersBlindnessBrainCataract ExtractionCerebrospinal FluidClinicalClinical TrialsCochlear ImplantsCognitiveCommunitiesComplexConsensusDataData CollectionDementiaDeteriorationDiagnosisDisease ProgressionElderlyFamilyFutureGaitGait abnormalityGait speedGoalsHealthHearing AidsImpaired cognitionImpairmentIndividualInterventionIntervention StudiesJointsKnowledgeLaboratoriesLife StyleLinkLongitudinal StudiesMagnetic Resonance ImagingMeasuresModelingMonitorMotionMotorMovementOperative Surgical ProceduresOutcomeParticipantPathogenicityPathologicPathologyPerformancePharmacologyPhasePhenotypePhysical FunctionPhysical activityPhysical therapyPhysiologicalPittsburgh Compound-BPositron-Emission TomographyPredictive ValueProceduresProspective StudiesProtocols documentationPsychometricsResearchResourcesRiskRoleSelf-Help DevicesSensorimotor functionsSensorySocietiesSymptomsTimeTrainingValidationVisitVisualVisual impairmentWorkabeta accumulationabeta depositionagedaging brainbasecerebral atrophycognitive functioncognitive performancecognitive testingdata resourcedisorder riskexperiencegait examinationhearing impairmenthigh riskimprovedinsightlensmild cognitive impairmentnovelperformance testspre-clinicalpre-clinical assessmentpredictive modelingpreventrehabilitation technologyrisk prediction modelsensorimotor systemtau Proteinstau aggregationtau-1
项目摘要
PROJECT SUMMARY
Alzheimer's disease (AD) is the most common cause of dementia. Underlying pathological and physiological
changes related to the onset and progression of AD are believed to emerge several years prior to clinical
manifestations. Sensory impairments, gait abnormalities, and motor slowing may precede the diagnosis of AD
by a decade or more, presenting the exciting possibility that changes in sensorimotor functioning may act as
early noninvasive biomarkers for AD. Previous work by our group has identified links between cognitive
performance and sensory impairment and gait speed and variability, making them potential preclinical markers
of early AD pathology. We propose to use up to 10 years of existing longitudinal data, and ongoing/new data
collection in approximately 1,000 older adults in the Baltimore Longitudinal Study of Aging (BLSA), to examine
the roles of sensory function, gait speed and variability, and free-living measures of daily physical activity (PA)
as precursors to cognitive impairment. We will also determine the link between sensorimotor measures and
biomarkers of AD pathology, including Aβ deposition using [11C]-Pittsburgh compound B positron emission
tomography, brain atrophy using structural magnetic resonance imaging (MRI), Tau and pTau from cerebrospinal
fluid, and cognitive performance. We will further utilize the rich data resources of the BLSA to develop a
parsimonius prediction model for risk of progression to MCI/AD, and validate its performance in the
Atherosclerosis Risk in Communities (ARIC) study. A better understanding of the associations among
sensorimotor changes, subclinical AD pathology, and cognitive performance may elucidate a high-risk phenotype
that is associated with increased risk of poor cognitive outcomes over time and increase our understanding of
the complex associations among declines in sensory, physical, and cognitive functioning with age. To this end,
future intervention studies of AD prevention might screen for sensorimotor impairments as a high-risk phenotype
reflective of increased risk for developing AD, which could serve as surrogate outcomes in clinical trials.
Moreover, sensorimotor impairments may present feasible and modifiable targets for AD prevention by
identifying critical threshold(s) for implementation of assistive and rehabilitative technologies such as hearing
aids, corrective lenses, surgical or pharmacologic procedures to correct hearing and/or vision impairment (e.g.,
cataract surgery, cochlear implants), and physical therapy/timing and coordination of movement training to
correct gait abnormalities.
项目摘要
阿尔茨海默病(AD)是痴呆症最常见的原因。潜在的病理和生理
据信,与AD的发作和进展相关的变化在临床治疗前几年出现。
表现。感觉障碍、步态异常和运动减慢可能先于AD的诊断
十年或更长时间,提出了令人兴奋的可能性,即感觉运动功能的变化可能会作为
AD的早期非侵入性生物标志物。我们小组以前的工作已经确定了认知和行为之间的联系。
性能和感觉障碍以及步态速度和变异性,使其成为潜在的临床前标志物
早期AD病理学。我们建议使用长达10年的现有纵向数据和正在进行的/新的数据
在巴尔的摩老龄化纵向研究(BLSA)中,收集了大约1,000名老年人的样本,
感觉功能、步态速度和变异性以及日常体力活动(PA)的自由生活措施的作用
是认知障碍的前兆我们还将确定感觉运动测量与
AD病理学的生物标志物,包括使用[11 C]-匹兹堡化合物B正电子发射的Aβ沉积
断层扫描,使用结构磁共振成像(MRI)的脑萎缩,来自脑脊液的Tau和pTau
流体和认知性能。我们会进一步利用劳工统计局丰富的数据资源,
进展为MCI/AD风险的parsimonius预测模型,并验证其在
社区动脉粥样硬化风险(ARIC)研究。更好地理解这些联系,
感觉运动改变、亚临床AD病理学和认知表现可能阐明了高风险表型
随着时间的推移,这与认知结果不佳的风险增加有关,并增加我们对
随着年龄的增长,感觉、身体和认知功能的下降之间存在着复杂的联系。为此目的,
未来的AD预防干预研究可能会将感觉运动障碍作为高危表型进行筛查
这反映了发展AD的风险增加,这可以作为临床试验中的替代结果。
此外,感觉运动障碍可能是预防AD的可行和可修改的目标,
确定实施听力等辅助和康复技术的关键门槛
助听器、矫正镜片、矫正听力和/或视力损伤的外科或药物程序(例如,
白内障手术,人工耳蜗植入),以及物理治疗/运动训练的时机和协调,
纠正步态异常。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuri Agrawal其他文献
Yuri Agrawal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuri Agrawal', 18)}}的其他基金
Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease
前庭疗法减少阿尔茨海默病患者跌倒的临床试验
- 批准号:
10611308 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10274617 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10487441 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10643891 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease
前庭疗法减少阿尔茨海默病患者跌倒的临床试验
- 批准号:
10341139 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Impact of vestibular loss on central vestibular pathways in aging adults
前庭丧失对老年人中枢前庭通路的影响
- 批准号:
10990150 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Clinical trial of vestibular therapy to reduce falls in patients with Alzheimer's disease
前庭疗法减少阿尔茨海默病患者跌倒的临床试验
- 批准号:
10993253 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Contribution of sensorimotor function to risk and pathogenic mechanisms of Alzheimer's disease and related dementias
感觉运动功能对阿尔茨海默病和相关痴呆的风险和致病机制的贡献
- 批准号:
10534237 - 财政年份:2019
- 资助金额:
$ 72.9万 - 项目类别:
Does vestibular loss predict falls in patients with Alzheimer's Disease?
前庭丧失是否预示着阿尔茨海默病患者会跌倒?
- 批准号:
9915832 - 财政年份:2018
- 资助金额:
$ 72.9万 - 项目类别:
Does vestibular loss predict falls in patients with Alzheimer's Disease?
前庭丧失是否预示着阿尔茨海默病患者会跌倒?
- 批准号:
9763435 - 财政年份:2018
- 资助金额:
$ 72.9万 - 项目类别:
相似海外基金
Establishing best practices for the use of accelerometer measured ambient light sensor data to assess children's outdoor time
建立使用加速度计测量的环境光传感器数据来评估儿童的户外时间的最佳实践
- 批准号:
10731315 - 财政年份:2023
- 资助金额:
$ 72.9万 - 项目类别:
Training of machine learning algorithms for the classification of accelerometer-measured bednet use and related behaviors associated with malaria risk
训练机器学习算法,用于对加速计测量的蚊帐使用和与疟疾风险相关的相关行为进行分类
- 批准号:
10727374 - 财政年份:2023
- 资助金额:
$ 72.9万 - 项目类别:
Development of environmentally robust and thermally stable Microelectromechanical Systems (MEMS) based accelerometer for automotive applications
开发适用于汽车应用的环境稳定且热稳定的微机电系统 (MEMS) 加速度计
- 批准号:
566730-2021 - 财政年份:2022
- 资助金额:
$ 72.9万 - 项目类别:
Alliance Grants
Use of accelerometer and gyroscope data to improve precision of estimates of physical activity type and energy expenditure in free-living adults
使用加速度计和陀螺仪数据来提高自由生活成年人身体活动类型和能量消耗的估计精度
- 批准号:
10444075 - 财政年份:2022
- 资助金额:
$ 72.9万 - 项目类别:
Use of accelerometer and gyroscope data to improve precision of estimates of physical activity type and energy expenditure in free-living adults
使用加速度计和陀螺仪数据来提高自由生活成年人身体活动类型和能量消耗的估计精度
- 批准号:
10617774 - 财政年份:2022
- 资助金额:
$ 72.9万 - 项目类别:
Investigating the validity and reliability of accelerometer-based measures of physical activity and sedentary time in toddlers (iPLAY)
研究基于加速度计的幼儿体力活动和久坐时间测量的有效性和可靠性 (iPLAY)
- 批准号:
475451 - 财政年份:2022
- 资助金额:
$ 72.9万 - 项目类别:
Studentship Programs
Exploration of novel pathophysiology of chemotherapy-induced peripheral neuropathy utilizing quantitative sensory testing and accelerometer
利用定量感觉测试和加速度计探索化疗引起的周围神经病变的新病理生理学
- 批准号:
22K17623 - 财政年份:2022
- 资助金额:
$ 72.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigating the reliability of accelerometer-based measures of physical activity and sedentary time in toddlers
研究基于加速度计的幼儿体力活动和久坐时间测量的可靠性
- 批准号:
466914 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Studentship Programs
Doctoral Dissertation Research: Leveraging Intensive Time Series of Accelerometer Data to Assess Impulsivity and Inattention in Preschool Children
博士论文研究:利用加速计数据的密集时间序列来评估学龄前儿童的冲动和注意力不集中
- 批准号:
2120223 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Standard Grant
Development of a rotation-invariant accelerometer for human activity recognition
开发用于人类活动识别的旋转不变加速度计
- 批准号:
21K19804 - 财政年份:2021
- 资助金额:
$ 72.9万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)